GSTA5: A Potential Drug Target for Various Diseases (G221357)

Target Name: GSTA5

NCBI ID: G221357

GSTA5

GSTA5: A Potential Drug Target for Various Diseases

Glutathione S-Transferase Alpha 5 (GSTA5) is a protein that is expressed in most tissues of the body and plays a critical role in the immune system. It is a member of the superfamily of transmembrane proteinases and is responsible for the transfer of glutathione, a naturally occurring antioxidant, from the cell surface to the cytosol. GSTA5 is a key enzyme in the detoxification process of xenobiotics, which are foreign substances that can cause harm to the body.

GSTA5 is also involved in the regulation of cellular signaling pathways, including the T-cell receptor signaling pathway. This pathway is important for the development and maintenance of T-cell immunity and is a potential target for cancer therapy.

In addition to its role in immune function, GSTA5 has also been shown to have a variety of non-immunological functions. For example, it is involved in the regulation of cell death, cell signaling, and cell-cell fusion. It is also thought to play a role in the development and maintenance of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

GSTA5 is a protein that is expressed in most tissues of the body and is involved in a variety of cellular processes that are important for the development and maintenance of health. As a result, it is a potential drug target and could be useful in the treatment of a variety of diseases.

GSTA5 has been shown to have a variety of potential drug-like properties, including its ability to inhibit the activity of cancer cells in cell culture and its ability to protect against oxidative stress. In addition, GSTA5 has been shown to have a variety of interactions with other proteins, including the T-cell receptor signaling pathway. This suggests that it may be a useful target for cancer therapy.

GSTA5 is also involved in the regulation of cellular signaling pathways and is thought to play a role in the development and maintenance of neurodegenerative diseases. This suggests that it may be a useful target for the treatment of these diseases as well.

In conclusion, GSTA5 is a protein that is involved in a variety of cellular processes that are important for the development and maintenance of health. As a result, it is a potential drug target and could be useful in the treatment of a variety of diseases. Further research is needed to fully understand the role of GSTA5 in the immune system and its potential as a drug target.

Protein Name: Glutathione S-transferase Alpha 5

The "GSTA5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GSTA5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets